<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2014-5-403-408</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-725</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>ГОМЕОСТАТИЧЕСКАЯ ПРОЛИФЕРАЦИЯ КАК ОСНОВА НЕИЗБЕЖНОГО ФОРМИРОВАНИЯ ТОТАЛЬНОГО ИММУНОДЕФИЦИТА</article-title><trans-title-group xml:lang="en"><trans-title>HOMEOSTATC PROLIFERATION AS A BASIS FOR THE INEVITABLE FORMATION OF TOTAL IMMUNODEFICIENCY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, академик РАН, директор ФГБУ «НИИ клинической иммунологии» СО РАМН 630090, Россия, г. Новосибирск, ул. Ядринцевская, 14. Тел.: 8 (383) 222-66-27. Факс: 8 (383) 222-70-28</p></bio><bio xml:lang="en"><p>PhD, MD, Professor, Full Member of Russian Academy of Medical Sciences, Director, Research Institute of Clinical Immunology, Siberian Branch, Russian Academy of Medical Sciences 630090, Russian Federation, Novosibirsk, Yadrintsevskaya str., 14. Phone: 7 (383) 222-66-27. Fax: 7 (383) 222-70-28.</p></bio><email xlink:type="simple">vakoz40@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «НИИ клинической иммунологии» СО РАМН, г. Новосибирск, Россия<country>Россия</country></aff><aff xml:lang="en">Research Institute of Clinical Immunology, Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk, Russian Federation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>22</day><month>11</month><year>2014</year></pub-date><volume>16</volume><issue>5</issue><fpage>403</fpage><lpage>408</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Козлов А.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Козлов А.В.</copyright-holder><copyright-holder xml:lang="en">Kozlov V.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/725">https://www.mimmun.ru/mimmun/article/view/725</self-uri><abstract><p>Многочисленные литературные данные свидетельствуют о постепенном, но неуклонном снижении иммунологической реактивности организма, уменьшении его способности формировать специфический иммунный ответ как клеточного, так и гуморального типа. Результатом подобного рода изменений является увеличение частоты различного рода заболеваний, включая онкологические и аутоиммунные. В конце концов, даже в нормальном организме, без явных проявлений патологии, формируется старческий иммунодефицит, механизмы которого остаются до конца не выясненными. Ясно, по-видимому, только одно, что они многокомпонентные. Можно предположить, что одним из этих механизмов, который может стать ведущим, является процесс гомеостатической пролиферации, сопровождающий любые негативные влияния на численность лимфоцитов в организме и проявляющийся уменьшением способности лимфоцитов узнавать чужеродные антигены на фоне увеличения аутореактивных клеток.</p></abstract><trans-abstract xml:lang="en"><p>Numerous literature data indicate to gradual, but steady ageependent decrease of immunological reactivity in human organism, manifesting as a reduced ability to develop specific immune response, both of cellular and humoral type. Such negative trends result into increased proposition and frequency of various diseases, including cancer and autoimmune disorders. Finally, an age-associated immunodeficiency is developed even in normal organism, without clear background of specific disorders. The multicomponent mechanisms of such deficiency are not yet fully clarified. One may assume that, among these potentially leading mechanisms, a homeostatic proliferation may be of sufficient importance. This type of cell growth is shown to accompany any negative effects on the numbers of lymphocytes in the body. It manifests as a reduced ability of lymphocytes to recognize foreign antigens associated with a background increase of self-reactive cells.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гомеостатическая пролиферация</kwd><kwd>иммунодефицит</kwd><kwd>наивные Т-клетки</kwd><kwd>Т-клетки памяти</kwd><kwd>апоптоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>homeostatic proliferation</kwd><kwd>immunodeficiency</kwd><kwd>na ve T cells</kwd><kwd>memory T cells</kwd><kwd>apoptosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов В.А. Свободная внеклеточная ДНК в норме и при патологии // Медицинская иммунология. 2013. Т. 15, № 5. С. 399-412. [Kozlov V.A. Svobodnaya vnekletochnaya DNK v norme i pri patologii [Free, extracellular dna in norm and pathology]. Meditsinskaya immunologiya = Medical Immunology, 2013, Vol. 15, no. 5, pp. 399-412].</mixed-citation><mixed-citation xml:lang="en">Козлов В.А. Свободная внеклеточная ДНК в норме и при патологии // Медицинская иммунология. 2013. Т. 15, № 5. С. 399-412. [Kozlov V.A. Svobodnaya vnekletochnaya DNK v norme i pri patologii [Free, extracellular dna in norm and pathology]. Meditsinskaya immunologiya = Medical Immunology, 2013, Vol. 15, no. 5, pp. 399-412].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Heninger A.K., Theil A., Petzold C., Huebel N., Kretschmer K., Bonifacio E., Monti P. IL-7 abrogates</mixed-citation><mixed-citation xml:lang="en">Heninger A.K., Theil A., Petzold C., Huebel N., Kretschmer K., Bonifacio E., Monti P. IL-7 abrogates</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">suppressive activity of human CD4+CD25+FoxP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells. J. Immunol., 2012, Vol. 189, no. 12, pp. 5649-5658.</mixed-citation><mixed-citation xml:lang="en">suppressive activity of human CD4+CD25+FoxP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells. J. Immunol., 2012, Vol. 189, no. 12, pp. 5649-5658.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hickman P.S., Turka L.A. Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos Trens R Soc Lond B Biol Sci., 2005, Vol. 360, no. 1461, pp. 1713-1721.</mixed-citation><mixed-citation xml:lang="en">Hickman P.S., Turka L.A. Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos Trens R Soc Lond B Biol Sci., 2005, Vol. 360, no. 1461, pp. 1713-1721.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kieper W.C., Burghardt J.T., Surt C.D. A role for TCR affinity in regulating na ve T cell homeostasis. J. Immunol., 2004, Vol. 172, no. 1, pp. 40-44.</mixed-citation><mixed-citation xml:lang="en">Kieper W.C., Burghardt J.T., Surt C.D. A role for TCR affinity in regulating na ve T cell homeostasis. J. Immunol., 2004, Vol. 172, no. 1, pp. 40-44.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kimmig S., Przybylski G.K., Schmidt C.A., Laurisch K., M wes B., Radbruch A., Thiel A. Two subset of naive helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med., 2002, Vol. 195, no. 6, pp. 789-794.</mixed-citation><mixed-citation xml:lang="en">Kimmig S., Przybylski G.K., Schmidt C.A., Laurisch K., M wes B., Radbruch A., Thiel A. Two subset of naive helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med., 2002, Vol. 195, no. 6, pp. 789-794.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Koetz K., Bryl E., Spickschen K., O’Fallon W.M., Goronzy J.J., Weyand C.M. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA, 2000, Vol. 97, no. 16, pp. 9203-9208.</mixed-citation><mixed-citation xml:lang="en">Koetz K., Bryl E., Spickschen K., O’Fallon W.M., Goronzy J.J., Weyand C.M. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA, 2000, Vol. 97, no. 16, pp. 9203-9208.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lario M., Munoz L., Ubeda M., Borrero M.-J., Martinez J. Defective thymopoiesis and poor peripheral homeostatic replenish-ment of T-helper cells cause T-cell lymphopenia in cirrhosis. J. Hepatology, 2013, Vol. 59, pp. 723-730.</mixed-citation><mixed-citation xml:lang="en">Lario M., Munoz L., Ubeda M., Borrero M.-J., Martinez J. Defective thymopoiesis and poor peripheral homeostatic replenish-ment of T-helper cells cause T-cell lymphopenia in cirrhosis. J. Hepatology, 2013, Vol. 59, pp. 723-730.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y., Lai L., Chen Q., Song Y., Xu S., Ma F., Wang X., Wang J., Yu H., Cao X., Wang Q. MicroRNA-494 is required for the accumulation and function of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J. Immunol., 2012, Vol. 188, pp. 5500-5510.</mixed-citation><mixed-citation xml:lang="en">Liu Y., Lai L., Chen Q., Song Y., Xu S., Ma F., Wang X., Wang J., Yu H., Cao X., Wang Q. MicroRNA-494 is required for the accumulation and function of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J. Immunol., 2012, Vol. 188, pp. 5500-5510.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nesic D., Vukmanoviċ S. MHC class I is required for peripheral accumulation of CD8+ thymic emigrants. J. Immunol., 1998, Vol. 160, no. 8, pp. 3705-3712.</mixed-citation><mixed-citation xml:lang="en">Nesic D., Vukmanoviċ S. MHC class I is required for peripheral accumulation of CD8+ thymic emigrants. J. Immunol., 1998, Vol. 160, no. 8, pp. 3705-3712.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Provinciali M., Moresi R., Donnini A., Lisa R.M. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly. Gerontology, 2009, Vol. 55, pp. 314-321.</mixed-citation><mixed-citation xml:lang="en">Provinciali M., Moresi R., Donnini A., Lisa R.M. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly. Gerontology, 2009, Vol. 55, pp. 314-321.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sport s C., Hakim F.T., Memon S.A., Zhang H., Chua K.S., Brown M.R., Fleisher T.A., Krumlauf M.C., Babb R.R., Chow C.K., Fry T.J., Engels J., Buffet R., Morre M., Amato R.J., Venzon D.J., Korngold R., Pecora A., Gress R.E., Mackall C.L. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of na ve T cell subsets. J. Exp. Med., 2008, Vol. 205, no. 7, pp. 1701-1714.</mixed-citation><mixed-citation xml:lang="en">Sport s C., Hakim F.T., Memon S.A., Zhang H., Chua K.S., Brown M.R., Fleisher T.A., Krumlauf M.C., Babb R.R., Chow C.K., Fry T.J., Engels J., Buffet R., Morre M., Amato R.J., Venzon D.J., Korngold R., Pecora A., Gress R.E., Mackall C.L. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of na ve T cell subsets. J. Exp. Med., 2008, Vol. 205, no. 7, pp. 1701-1714.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Takeda S., Rodewald H.R., Arakawa H., Bluethmann H., Shimizu T. MHC class II molecules are not required for survival of newly generated CD4+ T cell, but affect their long0term life span. Immunity, 1996, Vol. 5, no. 3, pp. 217-228.</mixed-citation><mixed-citation xml:lang="en">Takeda S., Rodewald H.R., Arakawa H., Bluethmann H., Shimizu T. MHC class II molecules are not required for survival of newly generated CD4+ T cell, but affect their long0term life span. Immunity, 1996, Vol. 5, no. 3, pp. 217-228.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Van Belle T.L., Dooms H., Boonefaes T., Wei X.Q., Leclercq G., Grooten J. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by in-habiting the suppressive function of CD25 high CD4+ T cells. PLoS One, 2012, Vol. 7, no. 9, e45299.doi:10.1371.</mixed-citation><mixed-citation xml:lang="en">Van Belle T.L., Dooms H., Boonefaes T., Wei X.Q., Leclercq G., Grooten J. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by in-habiting the suppressive function of CD25 high CD4+ T cells. PLoS One, 2012, Vol. 7, no. 9, e45299.doi:10.1371.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Weng N.P. Telomere and adaptive immunity. Mech Ageing Dev., 2008, Vol. 129, pp. 60-66.</mixed-citation><mixed-citation xml:lang="en">Weng N.P. Telomere and adaptive immunity. Mech Ageing Dev., 2008, Vol. 129, pp. 60-66.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wrzesinski S.H., Wan Y.Y., Flavell R.A. Transforming growth factor-β and immune response: implication for anticancer therapy. Clin Cancer Res., 2007, Vol. 13, no. 18, pp. 5262-5270.</mixed-citation><mixed-citation xml:lang="en">Wrzesinski S.H., Wan Y.Y., Flavell R.A. Transforming growth factor-β and immune response: implication for anticancer therapy. Clin Cancer Res., 2007, Vol. 13, no. 18, pp. 5262-5270.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
